PRCT Procept BioRobotics Corp
Price (delayed)
$57.74
Market cap
$3.17B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.75
Enterprise value
$2.91B
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic
Highlights
PRCT's gross profit has surged by 93% year-on-year and by 20% since the previous quarter
The equity has surged by 67% since the previous quarter and by 43% year-on-year
Key stats
What are the main financial stats of PRCT
Market
Valuations
Earnings
Shares outstanding
54.82M
Market cap
$3.17B
Enterprise value
$2.91B
Price to earnings (P/E)
N/A
Price to book (P/B)
7.49
Price to sales (P/S)
13.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.97
Revenue
$224.5M
Gross profit
$137.1M
Operating income
-$96.61M
Net income
-$91.41M
EBIT
-$87.23M
EBITDA
-$82.38M
Free cash flow
-$103.62M
Per share
Balance sheet
Liquidity
EPS
-$1.75
EPS diluted
-$1.75
Free cash flow per share
-$1.99
Book value per share
$7.71
Revenue per share
$4.31
TBVPS
$10.23
Total assets
$534.02M
Total liabilities
$131.8M
Debt
$80.25M
Equity
$402.22M
Working capital
$428.71M
Debt to equity
0.2
Current ratio
9.07
Quick ratio
7.85
Net debt/EBITDA
3.08
Margins
Efficiency
Dividend
EBITDA margin
-36.7%
Gross margin
61.1%
Net margin
-40.7%
Operating margin
-43%
Return on assets
-22%
Return on equity
-31.5%
Return on invested capital
-42.2%
Return on capital employed
-18.1%
Return on sales
-38.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRCT stock price
How has the Procept BioRobotics stock price performed over time
Intraday
1.14%
1 week
-7.36%
1 month
-10.26%
1 year
24.01%
YTD
-28.29%
QTD
-0.89%
Financial performance
How have Procept BioRobotics's revenue and profit performed over time
Revenue
$224.5M
Gross profit
$137.1M
Operating income
-$96.61M
Net income
-$91.41M
Gross margin
61.1%
Net margin
-40.7%
PRCT's gross profit has surged by 93% year-on-year and by 20% since the previous quarter
Procept BioRobotics's revenue has surged by 65% YoY and by 12% QoQ
The net margin is up by 48% year-on-year and by 19% since the previous quarter
The company's operating margin rose by 46% YoY and by 19% QoQ
Growth
What is Procept BioRobotics's growth rate over time
Valuation
What is Procept BioRobotics stock price valuation
P/E
N/A
P/B
7.49
P/S
13.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.97
Procept BioRobotics's EPS has increased by 22% YoY and by 10% QoQ
The equity has surged by 67% since the previous quarter and by 43% year-on-year
PRCT's P/B is 40% below its last 4 quarters average of 12.4
Procept BioRobotics's revenue has surged by 65% YoY and by 12% QoQ
The stock's price to sales (P/S) is 28% less than its last 4 quarters average of 18.4
Efficiency
How efficient is Procept BioRobotics business performance
Procept BioRobotics's return on sales has increased by 48% YoY and by 19% QoQ
The ROE has grown by 32% YoY and by 18% from the previous quarter
PRCT's ROIC is up by 32% YoY and by 14% QoQ
Procept BioRobotics's ROA has increased by 28% YoY and by 16% from the previous quarter
Dividends
What is PRCT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PRCT.
Financial health
How did Procept BioRobotics financials performed over time
The quick ratio has surged by 59% since the previous quarter and by 18% year-on-year
Procept BioRobotics's current ratio has soared by 51% from the previous quarter and by 19% YoY
The debt is 80% smaller than the equity
The equity has surged by 67% since the previous quarter and by 43% year-on-year
The debt to equity has declined by 39% since the previous quarter and by 29% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.